Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 10, 2015, Pages 1757-1766

  Krüger, Maximilian ^a   Pabst, Andreas Max ^a   Al Nawas, Bilal ^a   Horke, Sven ^a   Moergel, Maximilian ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Apoptosis; Irradiation; Oral squamous cell carcinoma; Oxidative stress; Paraoxonase 2; Reactive oxygen species

Indexed keywords

ARYLDIALKYLPHOSPHATASE 2; CASPASE 3; CASPASE 7; REACTIVE OXYGEN METABOLITE; ARYLDIALKYLPHOSPHATASE; PON2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER RADIOTHERAPY; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IRRADIATION; MOUTH SQUAMOUS CELL CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; CARCINOMA, SQUAMOUS CELL; METABOLISM; MITOCHONDRION; MOUTH NEOPLASMS; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; ARYLDIALKYLPHOSPHATASE; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; HUMANS; MITOCHONDRIA; MOUTH NEOPLASMS; OXIDATIVE STRESS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84939564851     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-1941-2     Document Type: Article

References (67)

1. Adam-Vizi V, Chinopoulos C (2006) Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 27:639–645. doi:10.1016/j.tips.2006.10.005
2. Altenhofer S et al (2010) One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J Biol Chem 285:24398–24403. doi:10.1074/jbc.M110.118604
3. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Investig 101:1581–1590. doi:10.1172/JCI1649
4. Benhar M, Dalyot I, Engelberg D, Levitzki A (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21:6913–6926. doi:10.1128/MCB.21.20.6913-6926.2001
5. Bourhis J et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843–854. doi:10.1016/S0140-6736(06)69121-6
6. Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106. doi:10.1080/10408360802610878
7. Chandra D, Singh KK (2011) Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta 1807:620–625. doi:10.1016/j.bbabio.2010.10.023
8. Chen Y et al (2012) Association analysis of PON polymorphisms in sporadic ALS in a Chinese population. Neurobiol Aging 33(2949):e2941–e2943. doi:10.1016/j.neurobiolaging.2012.06.024
9. Citak E, Tulek Z (2013) Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapy. Support Care Cancer 21:2171–2183. doi:10.1007/s00520-013-1774-y
10. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J17:1195–1214. doi:10.1096/fj.02-0752rev
11. Decaudin D, Marzo I, Brenner C, Kroemer G (1998) Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy (review). Int J Oncol 12:141–152
12. Devarajan A et al (2011) Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid Redox Signal 14:341–351. doi:10.1089/ars.2010.3430
13. Ding ZY, Liu GH, Olsson B, Sun XF (2012) Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells. Tumour Biol. doi:10.1007/s13277-012-0596-8
14. Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN (2000) Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275:33435–33442. doi:10.1074/jbc.M004543200
15. Eckert AW, Kappler M, Schubert J, Taubert H (2012) Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients. Oral Maxillofac Surg 16:189–196. doi:10.1007/s10006-012-0335-8
16. Eriksson D, Stigbrand T (2010) Radiation-induced cell death mechanisms. Tumour Biol 31:363–372. doi:10.1007/s13277-010-0042-8
17. Fang J, Nakamura H, Iyer AK (2007) Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 15:475–486. doi:10.1080/10611860701498286
18. Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G (2005) Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 9:361–367
19. Frank O et al (2006) Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia 20:1400–1407. doi:10.1038/sj.leu.2404270
20. Fribley AM et al (2014) Celastrol induces unfolded protein response-dependent cell death in head and neck cancer. Exp Cell Res. doi:10.1016/j.yexcr.2014.08.014
21. Fruehauf JP, Meyskens FL Jr (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789–794. doi:10.1158/1078-0432.CCR-06-2082
22. Gasco M, Crook T (2003) The p53 network in head and neck cancer. Oral Oncol 39:222–231
23. Hashibe M et al (2003) Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomark Prev 12:1509–1517
24. Horke S, Witte I, Wilgenbus P, Kruger M, Strand D, Forstermann U (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115:2055–2064. doi:10.1161/CIRCULATIONAHA.106.681700
25. Horke S, Witte I, Wilgenbus P, Altenhofer S, Kruger M, Li H, Forstermann U (2008) Protective effect of paraoxonase-2 against endoplasmic reticulum stress-induced apoptosis is lost upon disturbance of calcium homoeostasis. Biochem J416:395–405. doi:10.1042/BJ20080775
26. Horke S et al (2010) Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-l-homoserine lactone and attenuates oxidative stress induced by pyocyanin. Biochem J426:73–83. doi:10.1042/BJ20091414
27. Jerhammar F et al (2014) YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer. Oral Oncol. doi:10.1016/j.oraloncology.2014.06.003
28. Jonathan EC, Bernhard EJ, McKenna WG (1999) How does radiation kill cells? Curr Opin Chem Biol 3:77–83
29. Kang H et al (2010) Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood 115:1394–1405. doi:10.1182/blood-2009-05-218560
30. Khersonsky O, Tawfik DS (2005) Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry 44:6371–6382. doi:10.1021/bi047440d
31. Kishimoto K, Yoshida S, Ibaragi S, Yoshioka N, Okui T, Hu GF, Sasaki A (2012) Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer. Oral Oncol 48:1120–1127. doi:10.1016/j.oraloncology.2012.05.009
32. Korde SD, Basak A, Chaudhary M, Goyal M, Vagga A (2011) Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 80:382–389. doi:10.1159/000329811
33. Kutler DI et al (2003) High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 129:106–112
34. La Vecchia C, Lucchini F, Negri E, Levi F (2004) Trends in oral cancer mortality in Europe. Oral Oncol 40:433–439. doi:10.1016/j.oraloncology.2003.09.013
35. Lacko M et al (2014) Genetic susceptibility to head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 89:38–48. doi:10.1016/j.ijrobp.2013.09.034
36. Li Y et al (2002) Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J Cancer Res Clin Oncol 128:369–379. doi:10.1007/s00432-002-0347-0
37. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4:966–977. doi:10.1038/nrc1505
38. Malik UU, Siddiqui IA, Hashim Z, Zarina S (2014) Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clin Chim Acta 430C:38–42. doi:10.1016/j.cca.2013.12.033
39. Marsillach J, Mackness B, Mackness M, Riu F, Beltran R, Joven J, Camps J (2008) Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med 45:146–157. doi:10.1016/j.freeradbiomed.2008.03.023
40. Massano J, Regateiro FS, Januario G, Ferreira A (2006) Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:67–76. doi:10.1016/j.tripleo.2005.07.038
41. Moergel M, Goldschmitt J, Stockinger M, Kunkel M (2013) DeltaNp63 expression in four carcinoma cell lines and the effect on radioresistance-a siRNA knockdown model. Clin Oral Investig. doi:10.1007/s00784-013-1078-0
42. Ocker M, Hopfner M (2012) Apoptosis-modulating drugs for improved cancer therapy. Eur Surg Res 48:111–120. doi:10.1159/000336875
43. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12:913–922. doi:10.1007/s10495-007-0756-2
44. Panganiban RA, Mungunsukh O, Day RM (2013) X-irradiation induces ER stress, apoptosis, and senescence in pulmonary artery endothelial cells. Int J Radiat Biol 89:656–667. doi:10.3109/09553002.2012.711502
45. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
46. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498–507
47. Rasheed MH, Beevi SS, Geetha A (2007) Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 43:333–338. doi:10.1016/j.oraloncology.2006.02.013
48. Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J (2013) Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol 49:634–642. doi:10.1016/j.oraloncology.2013.02.013
49. Ribarska T, Ingenwerth M, Goering W, Engers R, Schulz WA (2010) Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma. Cancer Genomics Proteomics 7:51–60
50. Ricci MS, Zong WX (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11:342–357. doi:10.1634/theoncologist.11-4-342
51. Ross ME et al (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951–2959. doi:10.1182/blood-2003-01-0338
52. Rothenberg SM, Ellisen LW (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Investig 122:1951–1957
53. Schafer ZT et al (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461:109–113. doi:10.1038/nature08268
54. Schweikert EM et al (2012) PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. doi:10.1038/cdd.2012.35
55. Shih DM, Lusis AJ (2009) The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Curr Opin Lipidol 20:288–292. doi:10.1097/MOL.0b013e32832ca1ee
56. Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, LLeonart ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376–390. doi:10.1016/j.arr.2012.10.004
57. Srivastava KC, Austin RD, Shrivastava D, Sethupathy S, Rajesh S (2012) A Case control study to evaluate oxidative stress in plasma samples of oral malignancy. Contemp Clin Dent 3:271–276. doi:10.4103/0976-237X.103617
58. Stevens EA, Rodriguez CP (2014) Genomic medicine and targeted therapy for solid tumors. J Surg Oncol. doi:10.1002/jso.23699
59. Suh DH, Kim MK, Kim HS, Chung HH, Song YS (2012) Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Ann NY Acad Sci 1271:20–32. doi:10.1111/j.1749-6632.2012.06739.x
60. Suntharalingam M et al (2001) Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer 91:548–554
61. Trotti A et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262
62. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40. doi:10.1016/j.cbi.2005.12.009
63. Vaseva AV, Moll UM (2009) The mitochondrial p53 pathway. Biochim Biophys Acta 1787:414–420. doi:10.1016/j.bbabio.2008.10.005
64. Vaughn AE, Deshmukh M (2008) Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 10:1477–1483. doi:10.1038/ncb1807
65. Wang D, Kreutzer DA, Essigmann JM (1998) Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res 400:99–115
66. Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J313(Pt 1):17–29
67. Witte I et al (2011) Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells. Cell Death Dis 2:e112. doi:10.1038/cddis.2010.91